CLLS – cellectis s.a. - american depositary shares (US:NASDAQ)

News

Cellectis (CLLS) had its "market outperform" rating reaffirmed by Citizens Jmp. They now have a $8.00 price target on the stock.
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Cellectis S.A. (CLLS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update [Yahoo! Finance]
Cellectis Q4 2025 Earnings Preview [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com